Fiscal year 2023 neurotoxins exposure treatment to parkinson's research program programmatic review and vision setting

Ended Awarded Last action

Contract number
HT942523F0108
Awardee
Awarding agency
Obligated
$153,045

Award facts

Opportunity
Contract value 74% obligated
  • $153,045.28 Current, with exercised options
  • $206,338.84 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21703, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 · Fiscal year 2023 neurotoxin exposure treatment parkinsons research program vision setting, pre-application screening, programmatic review and general program… -$52,949
Funding Only Action P00002 · Fiscal year 2023 neurotoxin exposure treatment for parkinson's research program vision setting, pre-application screening, programmatic review and general… $50,864
Funding Only Action P00001 · Fiscal year 2023 neurotoxin exposure treatment in parkinson's research program vision setting, pre-APP screening and programmatic review $94,380
Original award $60,751

About this award

The Defense Health Agency issued a delivery order to Leidos, Inc. on May 1, 2023, with a ceiling value of $206,338.84 for Fiscal Year 2023 Neurotoxins Exposure Treatment to Parkinson's Research Program programmatic review and vision setting. The order is priced on a cost-plus-fixed-fee basis and is issued under an indefinite delivery contract vehicle.

Place of performance is Frederick, Maryland. The order is scheduled for completion by April 30, 2024. The scope includes fiscal year 2023 neurotoxin exposure treatment Parkinson's research program vision setting, pre-application screening, programmatic review, and general program support. No set-aside applies to this delivery order.

Quick answers

Who was awarded contract HT942523F0108?

HT942523F0108 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on May 1, 2023.

How much is contract HT942523F0108 worth?

The government has obligated $153,045 on HT942523F0108. Its potential value, with all options, is $206,339.

Is contract HT942523F0108 an order under another contract?

Yes. HT942523F0108 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942523F0108 competed?

The extent of competition for HT942523F0108 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award